A Randomized, Multiple Dose, Double Blind, 5-way Crossover Study of the Electrocardiographic (ECG) Effects of Bilastine

NCT00419783 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: bilastine
DRUG: Bilastine
DRUG: Bilastine & Ketoconazole
DRUG: Moxifloxacin
DRUG: Placebo

Sponsor

Faes Farma, S.A.